Food safety and quality for the consumer: Policies and communication by Foreman, Carol Tucker
Food Safety and Quality For The 
Consumer: Policies and Communication
Good morning. As a student thirty years ago, 8 a.m. 
classes were the bane of my existence. Any professor 
who hoped to keep me awake had to have the oral equi-
valent of the 1812 Overture. It is with that memory and 
concern that 1 would like to begin this morning with a 
few quotes:
Hydrochloric acid is the same acid contained in 
the human stomach. So said a spokesman for the So-
ciety of the Plastics Industry, on why plastic, which 
gives off hydrochloric acid when it is burned, could 
not be an environmental irritant.
Most of the chemicals are not a problem as far as 
adverse effects...The stuff you smell is not neces­
sarily anything to worry about. The reassuring re-
sponse of the Health Commissioner of Niagara 
County, New York, to the residents of the Love Ca-
nal area.
There was nothing there that was catastrophic or 
unplanned for. The calming response of the vice 
president for power generation of Metropolitan 
Edison, owner of Three Mile Island nuclear power 
plant, 1979.
A nuclear power plant is infinitely safer than eat­
ing, because 300 people choke to death on food ev­
ery year. Dixy Lee Ray, Governor of Washington, 
1977.
Opponents of peacetime applications of 2, 4, 5—T 
have repeatedly launched false, malicious attacks 
on the safety of the product. Dow Chemical Com-
pany fact sheet after an investigation concluded the 
manufacture of Agent Orange creates dioxin.
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DDT, the most effective pesticide, was outlawed on the theoretical 
grounds that it might someday, under some circumstances, harm 
someone. Ronald Reagan, 1978-Quoted in Arbeiter, Jean, No Matter 
How You Slice It, It's Still Baloney (Quill. New York, 1984.)
We must help the public understand that a genetically engineered to­
mato is still a tomato...and that this research is being conducted by 
responsible scientists operating under a strict and credible system of 
safety guidelines. Assistant Secretary of Agriculture Charles Hess,
1990 Remarks Prepared for Delivery to Conference on New Food and 
New Food Chemicals: Safety and Regulatory Considerations, at the Na-
tional Academy of Sciences, May 1,1990.
Consumers must understand they do not live in a risk-free society 
and that some risk is necessary for all the benefits that today's tech­
nology brings. Luther McKinney, Senior Vice President, Quaker Oats 
Company “Fields of Fear,” Choices, American Agricultural Association. 
First Quarter, 1990.
One of the hardest things in the world is to convey meaning accurate­
ly from one mind to another. Lewis Carroll
What we have here is a failure to communicate. Prison Warden to the 
still defiant prisoner, Luke, after he has put Luke in chains, compelled 
him to dig a hole and then knocked him into it...the motion picture Cool 
Hand Luke.
As we approach the twenty-first century, the further development of 
biotechnology holds the potential for enormous benefits to society. Advan-
ces in genetic engineering can improve health and control pollution. Bio-
technology can bring us more efficient agriculture by enhancing productiv-
ity of the land, reducing quantities of water and energy needed to raise a 
particular crop, and expanding the geographical range of many crops. 
Biotechnology can address important consumer concerns about food. It 
can: improve food safety by reducing the need to use insecticides and her-
bicides; improve nutritional value of food by helping to produce leaner 
meat; enhance the flavor and the processing capability of food; identify 
and reduce the microbial contamination that brings
Given these virtually 
indiaputabla banatita, 
ona wonders why tha 
erowda aran't cheer-
ing In the streets.
food-borne illness and death to thousands of Ameri-
cans each year.
Given these virtually indisputable benefits, one won-
ders why the crowds aren’t cheering in the streets.
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Why instead, are people concerned—even frightened—about the potential 
impact of biotechnology on our food supply and our lives? Why does Jere-
my Rifkin have an audience? Why do people buy Jack Doyle’s book? It can-
not be dismissed as just another example of America’s love of gothic tales 
and horror stories. What steps can the biotechnology industry and the gov-
ernment take to ensure that the American people are sufficiently comfort-
able with the purposes, benefits and application of biotechnology that 
they will not unduly restrict its development?
Reasons for Concern
There are a number of reasons that Americans are concerned about the 
impact of biotechnology. First, all understand that biotechnology involves 
certain potential risks. There may be health risks arising from the con-
sumption of plants that contain bacteria designed to kill pests. Genetical-
ly-engineered microorganisms may be capable of attacking other microor-
ganisms, plants and animals in unexpected ways. Species under attack by 
genetically-engineered organisms may develop resistance to the toxins. 
There is a threat of ecological damage, as well. The development of herbi-
cide-resistant plants may encourage the use of more, not less, of toxic ma-
terials which may harm wildlife. Biotechnology will surely bring socioeco-
nomic change that will harm some farmers and suppliers, while benefiting 
others. The debate about bovine somatotropin (BST) in Wisconsin contin-
ues to be driven by these concerns.
Second, the social and political context in which the biotechnology re-
volution is occurring is not conducive to an enthusiastic and unquestion-
ing acceptance of any new scientific or technological breakthrough. In 
the 1950s virtually all Americans believed that there was “Better Living 
Through Chemistry.” Today, we are not so sure about it. Americans have 
lived through forty years of “Don't Worry, Be Happy” philosophy about 
new technologies, many of which were put on the market without any ex-
amination of the potentially negative unintended consequences of their 
use. All were told of the promises and none of the problems with DDT, 
aerosol sprays, and nuclear power. When problems arose with some of the 
products, both government and industry were less than honest in report-
ing them. Today, Americans are more skeptical. Instead of accepting scien-
tific developments as a cornucopia, many see just another opportunity for 
Murphy’s Law to rule.
The public’s view of new science and technology is unquestionably col-
ored by this history, and their view of biotechnology will also be influenced
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There is an assump-
tion that, if the public 
can just be made to 
understand, it will 
open its arms and re-
ceive biotechnology 
as an unmitigated 
blessing.
by government’s and industry’s attempts to “communicate" the virtues of 
these new developments.
“Communication” Problem
The proponents of biotechnology have approached these public concerns 
as a “communication” problem. Considering the enthusiasm for this excit-
ing new field among those involved in it, that is not surprising. Some en-
thusiasts in government and the food industry believe the best approach to 
resolving fears about biotechnology specifically or the safety of the food 
supply generally is to “educate” the public.
In this case, “educate” should be read as “reassure." 
They believe public concerns are based on mispercep-
tions and unjustifiable fears. There is an assumption 
that, if the public can just be made to understand, it 
will open its arms and receive biotechnology as an un-
mitigated blessing.
Occasionally, efforts to “communicate” express less 
than a high regard for the intelligence of critics. In 
fact, they sometimes take on the tone of the old “Sat-
urday Night Live” satire of the Jack Kilpatrick—Shana Alexander face-offs 
on television news. You may remember the “Saturday Night Live” version 
would open with Jane Curtin giving her statement on an issue of the day. 
Dan Akroyd would then begin his rebuttal with, “Jane, you ignorant slut.” 
That tone creeps into food industry and even government responses to 
consumer concerns about food safety in general. People concerned about 
the long-term impact of pesticide residues or herbicide-resistant corn are 
viewed as a flock of Chicken Littles, clucking inanely that the sky is falling. 
Industry and government officials seem to assume that if they can just get 
the silly chickens to understand what a great thing this will be, they will 
snuggle up to it like a warm lightbulb on a cold night in the henhouse. The 
jarring, condescending quotes at the beginning of this paper are not atypi-
cal. Rather, they reflect a common tone in both advocacy and defense of 
new technologies.
There are two problems with the “communication” as “reassurance” ap-
proach. It misunderstands communication. Communication is not Me 
speak,—You listen...Me teach,—You learn. Me say,—You do. It is a two- 
way street. It requires that both parties have the opportunity to speak and 
to listen, to hear and be heard, to act and to respond.
More importantly, there is a problem with assuming that communica-
tion will resolve public concerns about biotechnology. Differences over
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this issue may represent not a failure to communi-
cate, but a conflict in values. The risks and benefits of 
biotechnology do not necessarily accrue to the same 
individuals or groups. Getting the farmer a herbicide- 
resistant crop does not necessarily get the consumer 
anything. Economic theory suggests that increased 
production will generate lower prices, but in the real 
marketplace, there are too many steps between farmer and consumer to 
assume or even hope that the savings will reach the ultimate retail 
purchaser. Some consumers may prefer to forego both the advantages and 
the threats of biotechnology. Consumers may feel there is no benefit to 
them in a technology that promises increased productivity, but does not 
promise that savings will be passed through to the purchaser. Small farm-
ers may fear that new products will put them at a competitive disadvan-
tage.
Assistant Secretary of Agriculture Charles Hess noted recently that the 
debate over BST is about social and economic policy, not about science. He 
is right. If it were simply about science, effective communication might ad-
dress the problem. But if it is about social and economic conflicts, a con-
flict of values and interests, communication alone will not do the job.
Resolving these conflicts requires a mediating institution. In a demo-
cratic society, conflicts of values are ultimately resolved by government— 
by legislators, by regulatory agencies and by courts. In our system, the 
public must be comfortable that the hard questions about biotechnology 
are being addressed effectively by the government. And they must believe 
that government’s first priority in this endeavor will be to protect public 
health.
That is not going to be easy. The biotechnology industry began to de-
velop rapidly about the same time the United States was entering a period 
of “deregulation.” Regulatory activity tends to run in cycles. From the 
early 1960s to the late 1970s regulation, especially regulation designed to 
promote health and safety and prohibit invidious discrimination, ex-
panded significantly. In the late 1970s, the public began to view this regu-
lation as partly responsible for the nation’s economic difficulty. President 
Jimmy Carter tried to rein in regulation. Four years later, President Ronald 
Reagan ran and was elected, in large part, because he promised to get gov-
ernment off the backs of American business and let the economy rebuild 
itself. Reagan appointed officials who were committed to cutting back on 
business regulation and on government services. Regulatory agency bud-
Communication is 
not, Me speak,—you 
listen...Me teach,— 
you learn. Me say,— 
you do. It is a two- 
way street.
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A substantial erosion 
of public confidence 
has grown out of the 
era of deregulation.
gets and staffs were cut and new regulations were reviewed and frequently 
killed by the Office of Management and Budget.
A substantial erosion of public confidence has grown out of the era of 
deregulation. We have a tradition of limited government but we expect
government to ensure that our planes are safe and rea-
sonably on time, that purchasing a telephone will 
take less time than buying a house, that air and water 
and food are reasonably clean and that the money we 
put in a Savings and Loan will be safe. After a dozen 
years, “deregulation” is wearing thin.
Nowhere is this concern with the effects of less government control more 
evident than in the public concern about the environment and the safety 
of food and water. The scandals of the EPA during the reign of Anne 
Gorsuch and Rita Levelle and the attack on environmental laws by Secre-
tary James Watt have undermined public confidence that government 
agencies are working hard to protect public health and safety and the envi-
ronment. The results have included a willingness to believe sensationalist 
attacks and a growing reliance on responsive state regulation, rather than 
unresponsive federal regulation.
President George Bush and the Congress are moving to try to restore 
some confidence in the regulatory agencies, trying to increase budgets, 
hampered by the budget deficit. The Bush regulatory team, like the Presi-
dent, appears to be less ideological and more committed to making govern-
ment work. However, we will live with the legacy of the 1980s and efforts 
to generate support for biotechnology must take into account the context 
of American society today. There is little trust that the federal government 
will play a vigorous role in protecting the people or the environment. At
the same time, American business, including the bio- 
tlicts requires a medi- technol°gy industry, fear the delay and adversarial 
ating institution. nature of the regulatory process and the possibility of 
50 or more different sets of state and local regulations,
Benefiting From Biotechnology, Safely
If we want to enjoy the benefits of biotechnology while saving ourselves 
from unintended negative consequences, we need to take some specific 
steps.
First, the President of the United States should find an occasion to state 
simply, plainly and very strongly that the very first concern of the govern-
ment will be the health and safety of the American people and that the de-
velopment of biotechnology will be allowed to proceed only as long as it
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can be shown to be safe. True conservatism, not libertarianism, is an ap-
propriate approach for the leader of the party of Teddy Roosevelt.
The industry should not fear such a statement. Surely this view is held
by everyone involved in the development of biotechnology. This new field
may hold great hope for our nation's international competitiveness and for
improving products, but no one wants it at the risk of public safety. The
President should say that.
Second, the Administration, with support of the
... activists are      biotechnology industry, should propose changes in regu-
going to have a    latory procedures and the law, if necessary, to open regulatory
role in regulatory
decision making    processes to a very high level of public participa-
tion and make funds available to support vigorous public 
participation.
Let me talk a few minutes about “public participation.” It is not the same 
thing as public relations. There are several “publics” that must be ad-
dressed. They include: —environmental and consumer activists who fol-
low the progress of new technology and new regulations closely;—state 
and local public officials;—national and local media and the public at large.
The first three groups will have a major impact on what the last group 
thinks and how they react. Despite the worst fears of industry and govern-
ment, activists are going to have a role in regulatory decision making. The 
sooner they are involved and the better equipped they are to address the 
scientific and technical issues involved in a decision, the less impact they 
will have on the timing and perhaps the substance of regulatory decision 
making.
It is not enough to file a notice in the Federal Register to hold a hearing. 
Nor will it do much good to try to go around those most likely to raise dif-
ficult questions. If there are value conflicts to be resolved, knowing what 
they are early should improve the decision making process. If businesses 
and government know, in advance, and before they are committed to a 
course of action, what issues are likely to cause the greatest protest by con-
sumer and environmental activists, alternative courses can be adopted. 
Relatively small changes early in the process may save substantial amounts 
of time and money later.
Third, it would be useful to create a quasi- or non- governmental medi-
ating organization to deal with specific issues. There are some interesting 
examples of groups that have worked over a period of years to ease regula-
tory issues. The Joint Labor Management Committee of the Food Industry
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involves the major retailers and the trade unions that organize them. They 
meet regularly to try to avoid the most divisive industry wide issues. The 
Health Effects Institute is a private, non-profit organization funded by 
government money authorized under the Clean Air Act and the auto in-
dustry to set and carry out a research agenda on major auto-related clean 
air problems. A variation of this group could help set the research agenda 
for major biotechnology questions. It should involve individual scientists 
who are known to have a strong environmental bent.
Reducing conflict will not be easy and many fear both delay and the 
threat to trade secrets that may be involved. Industry leaders also may fear 
that they will participate in such an activity, only to be attacked by some 
activist not involved in the process. Any and all of those things may hap-
pen, but history indicates that a considered approach to the introduction 
of new technology provides the greatest opportunity to avoid unintended 
and unpleasant consequences. Moreover, Congress, regulatory agencies, 
the media, state and local officials and the public at large are likely to be 
impressed by any decision which has the endorsement of leaders of both 
consumer and environmental organizations and biotechnology leaders, 
and that certainly is possible.
These kinds of changes in the decision-making apparatus can improve 
“communication,” reduce value conflicts, and ultimately improve the pub-
lic policies governing biotechnology. Perhaps we can write this chapter of 
American history without creating another set of painful misjudgments.
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